Main > Drugs> Korvalment

Korvalment

Korvalment – drug with the vasodilating and calming the central nervous system action.

Form of release and structure

The Korvalment is released in the form of capsules: gelatinous, soft, spherical or spherical shape, with a seam, from light brownish-yellow till weak-yellow color or colourless, filled transparent oily with a yellowish shade or colourless liquid, with a menthol smell (on 10 pieces in blisters, on 3 blisters in a cardboard pack).

Is a part of 1 capsule:

  • Active agent: menthol solution in mentilovy ether of isovaleric acid – 100 mg;
  • Auxiliary components: gelatinous cover of the capsule (gelatin, пропилпарагидроксибензоат (Е 216), methylparahydroxybenzoate (Е 218), glycerin).

Indications to use

  • The stenocardia attacks proceeding benign;
  • Hysteria, neurosises;
  • The headache connected using nitrates;
  • Sea and aeroembolism (as antiemetic).

Contraindications

  • The expressed arterial hypotension;
  • Acute disorders of cerebral circulation;
  • Acute myocardial infarction;
  • Children's age (due to the lack of experience of use of drug for this group of patients);
  • Hypersensitivity to drug components.

At heavy attacks of stenocardia it is not recommended to use drug.

The feeding and pregnant women can carry out therapy in cases if the expected effect for health of mother is higher than possible risk for a child/fruit.

Sugar therefore patients with a diabetes mellitus can accept drug is not Korvalment's part.

Route of administration and dosage

The Korvalment should be accepted under language, keeping the capsule before its full dissolution under language (for acceleration of effect the cover can be crushed teeth).

Single dose at stenocardia attacks – 1 capsule. Frequency rate of administration of drug is defined by the frequency of emergence of attacks.

The maximum daily dose of Korvalment in case of need treatments of stenocardia and other states – 600 mg (6 capsules).

Therapy duration – up to 7 days.

Side effects

In isolated cases at Korvalment's use can arise: dacryagogue, discomfort in a stomach, nausea, dizziness.

At long use drowsiness and short-term arterial hypotension can develop. As a rule, these disturbances have short-term character and take place independently.

Also during treatment development of allergic reactions, including rash, a Quincke's edema, an itch is possible.

Special instructions

Because of possible side effects in the form of dizziness and drowsiness, during the first hours after Korvalment's reception it is necessary to be careful at control of vehicles or the performance of work requiring special attention.

Medicinal interaction

Simultaneous use of Korvalment with the medicines promoting improvement of exchange processes (vitamins, an asparkam, inosine) is allowed.

The Korvalment can strengthen effect of hypotensive drugs, sedation of opioid analgetics, psychotropic drugs, anesthetics and alcohol.

Simultaneous use of Korvalment with the neurotropic medicines oppressing the central nervous system can cause drowsiness.

Terms and storage conditions

To store in the place, unavailable to children, at a temperature of 5-25 °C.

Period of validity – 2 years.

 
 
Whether you know that:

Was considered earlier that yawning enriches an organism with oxygen. However this opinion was disproved. Scientists proved that yawning, the person cools a brain and improves its working capacity.